Naturhouse Health (UK) Performance
| 0R9G Stock | 1.70 0.01 0.59% |
The company secures a Beta (Market Risk) of 0.16, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Naturhouse Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Naturhouse Health is expected to be smaller as well. At this point, Naturhouse Health has a negative expected return of -0.28%. Please make sure to verify Naturhouse Health's information ratio, total risk alpha, potential upside, as well as the relationship between the jensen alpha and treynor ratio , to decide if Naturhouse Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Naturhouse Health SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | Some May Be Optimistic About Naturhouse Healths Earnings - Simply Wall St | 10/07/2024 |
| Total Cashflows From Investing Activities | -5.2 M |
Naturhouse |
Naturhouse Health Relative Risk vs. Return Landscape
If you would invest 206.00 in Naturhouse Health SA on August 28, 2024 and sell it today you would lose (36.00) from holding Naturhouse Health SA or give up 17.48% of portfolio value over 90 days. Naturhouse Health SA is generating negative expected returns and assumes 1.7108% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Naturhouse, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Naturhouse Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Naturhouse Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Naturhouse Health SA, and traders can use it to determine the average amount a Naturhouse Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1638
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0R9G |
Estimated Market Risk
| 1.71 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Naturhouse Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Naturhouse Health by adding Naturhouse Health to a well-diversified portfolio.
Naturhouse Health Fundamentals Growth
Naturhouse Stock prices reflect investors' perceptions of the future prospects and financial health of Naturhouse Health, and Naturhouse Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Naturhouse Stock performance.
| Return On Equity | 0.34 | ||||
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 78.45 M | ||||
| Shares Outstanding | 59.99 M | ||||
| Price To Sales | 1.88 X | ||||
| Revenue | 49.9 M | ||||
| Gross Profit | 37.24 M | ||||
| EBITDA | 14.71 M | ||||
| Net Income | 9.63 M | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | 7.1 M | ||||
| Earnings Per Share | 0.22 X | ||||
| Retained Earnings | 6.63 M |
About Naturhouse Health Performance
Assessing Naturhouse Health's fundamental ratios provides investors with valuable insights into Naturhouse Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Naturhouse Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Naturhouse Health is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Naturhouse Health performance evaluation
Checking the ongoing alerts about Naturhouse Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Naturhouse Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Naturhouse Health generated a negative expected return over the last 90 days | |
| Naturhouse Health may become a speculative penny stock | |
| Naturhouse Health is unlikely to experience financial distress in the next 2 years | |
| About 78.0% of the company shares are owned by insiders or employees |
- Analyzing Naturhouse Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Naturhouse Health's stock is overvalued or undervalued compared to its peers.
- Examining Naturhouse Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Naturhouse Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Naturhouse Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Naturhouse Health's stock. These opinions can provide insight into Naturhouse Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Naturhouse Stock Analysis
When running Naturhouse Health's price analysis, check to measure Naturhouse Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Naturhouse Health is operating at the current time. Most of Naturhouse Health's value examination focuses on studying past and present price action to predict the probability of Naturhouse Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Naturhouse Health's price. Additionally, you may evaluate how the addition of Naturhouse Health to your portfolios can decrease your overall portfolio volatility.